Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences - Tập 879 - Trang 1573-1586 - 2011
Tài liệu tham khảo
Adam, 2002, J. Med. Chem., 45, 1806, 10.1021/jm011107f
Bom, 2002, Angew. Chem. Int. Ed. Engl., 41, 266, 10.1002/1521-3773(20020118)41:2<265::AID-ANIE265>3.0.CO;2-Q
Bom, 2007, Curr. Opin. Pharmacol., 7, 298, 10.1016/j.coph.2006.11.009
Jones, 2008, Anesthesiology, 109, 816, 10.1097/ALN.0b013e31818a3fee
Blobner, 2010, Eur. J. Anaesthesiol., 27, 874, 10.1097/EJA.0b013e32833d56b7
Khuenl-Brady, 2010, Anesth. Analg., 110, 64, 10.1213/ane.0b013e3181ac53c3
Lemmens, 2010, BMC Anesthesiol., 10, 15, 10.1186/1471-2253-10-15
Epemolu, 2002, Rapid Commun. Mass Spectrom., 16, 1946, 10.1002/rcm.812
de Kam, 2010, Clin. Drug Investig., 30, 599, 10.2165/11537210-000000000-00000
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Bioanalytical Method Validation. May 2001. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf (accessed 20.07.10).
Zwiers, 2011, Clin. Drug Investig., 31, 101, 10.1007/BF03256937
Ploeger, 2009, Anesthesiology, 110, 95, 10.1097/ALN.0b013e318190bc32
de Kam, 2009, Anesthesiology, A429
Gijsenberg, 2005, Anesthesiology, 103, 695, 10.1097/00000542-200510000-00007
Peeters, 2010, Clin. Drug Investig., 30, 867, 10.1007/BF03256915
Sorgenfrei, 2006, Anesthesiology, 104, 667, 10.1097/00000542-200604000-00009
Suy, 2007, Anesthesiology, 106, 283, 10.1097/00000542-200702000-00016
Plaud, 2009, Anesthesiology, 110, 284, 10.1097/ALN.0b013e318194caaa
McDonagh, 2011, Anesthesiology, 114, 318, 10.1097/ALN.0b013e3182065c36
Staals, 2010, Br. J. Anaesth., 104, 31, 10.1093/bja/aep340
Peeters, 2011, Biopharm. Drug Dispos, 32, 159, 10.1002/bdd.747